Such cells control aggressive immune cells and, thus, unwanted immune reactions by the graft can be avoided. However, to date, there were no adequate techniques available to securely isolate the regulatory T cells.
Now, researchers of the Max Delbrück Center (MDC), Germany and their colleagues of the 'Fondazione Santa Lucia' in Rome, Italy have developed a simple method to specifically isolate these cells from human blood. (Blood)*.
According to the American Cancer Society, about 188,000 people world-wide developed leukaemia in 2007. Predominantly immature white blood cells can be found in their blood. These cells displace the healthy cells and, thus, suppress Blood a normal haematopoiesis. Chemotherapy destroys the diseased cells of the patient which then often have to be replaced by a bone marrow graft.
"However," says Dr. Markus Kleinewietfeld (MDC), "in 30 to 50 percent of the patients, the aggressive immune cells contaminating the bone marrow graft direct themselves against the recipient." This often lethal defence reaction is called 'Graft versus Host Disease' (GvHD). Yet, with the help of regulatory T cells from the blood of the donor, the rejection reaction might be suppressed.
"Until now, it was not possible to securely isolate regulatory T cells in their pure form," explains Dr. Kleinewietfeld. Since, in humans, the cell surface marker (CD25) used for the isolation before is also found on the aggressive immune cells, it was hardly possible to clearly separate the helpful Tregs from the dangerous cells.
With other markers (CD49d and CD127), the scientists now succeeded in separating the aggressive and dangerous immune cells from the helpful, regulatory cells. Thus, it is now possible to isolate regulatory T cells in high purity safely from human blood. Using these T cells, the researchers could already suppress a particular severe form of the 'Graft versus Host Disease' in mice. In a first clinical trial in Singapore, the MDC researchers now want to apply the regulatory cells in leukaemia patients who developed the severe immune reaction after a bone marrow donation.
"Singapore provides the infrastructure and financial commitment necessary for such trials," says Dr. Olaf Rötzschke, a former MDC researcher who now works at the 'Singapore Immunology Network' (SIgN) of the BIOPOLIS Campus. "Dependent on the outcome of this clinical test, regulatory T cells could possibly be used also for the treatment of autoimmune diseases, allergies and tissue rejections in the future," hopes Dr. Kirsten Falk, head of the MDC research group.
*Blood: doi 10 1182/blood-2008-04-150524
CD49d provides access to 'untouched' human Foxp3+ Treg free of contaminating effector cells
Markus Kleinewietfeld1, Mireille Starke1, Diletta Di Mitri2, Giovanna Borsellino2, Luca Battistini2, Olaf Rötzschke1,3, Kirsten Falk11Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, D-13125 Berlin, Germany
3Singapore Immunology Network (SIgN), 8A Biomedical Grove, IMMUNOS, Singapore 138648, SingaporeBarbara Bachtler
Barbara Bachtler | idw
Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute
Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy